Cipher Pharmaceuticals Appoints Louise Blythe as Vice President, Regulatory Affairs and Brian Rosenberger as Vice President, Alliance and Strategic Portfolio Management

By: via Benzinga
Cipher Pharmaceuticals Inc. (NASDAQ:CPHR; TSX:CPH) ("Cipher" or "the Company") today announced the appointments of Louise Blythe as Vice ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.